CPCF and PQS


 

Community Pharmacy Contractual Framework (CPCF)

Pharmacy Quality Scheme (PQS) 2020/21

Following the peak of the COVID-19 pandemic, PSNC agreed the requirements for a new Pharmacy Quality Scheme (PQS) for 2020/21 with the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I).

The scheme has two parts, the first of which was announced on 13th July 2020. The focus of the Part 1 scheme is ensuring community pharmacy contractors and their teams have put in place all reasonable measures to respond to the COVID-19 pandemic, protecting both themselves and the people using their services.

That scheme is also a Gateway requirement for the Part 2 scheme, which is also focused on activities that support the response to and recovery from the COVID-19 pandemic. An early view of the contents of the Part 2 scheme was published on 6th August 2020, with the full details being released in the September 2020 Drug Tariff on 27th August 2020.

Part 1 PQS 2020/21

Details and the action checklist can be found at:

View the Part 1 2020/21 PQS Checklist and PSNC support materials

A new Pharmacy Quality Scheme (PQS) for the first part of 2020/21 has been announced today (13th July 2020). The focus of the scheme is ensuring community pharmacy contractors and their teams have put in place all reasonable measures to respond to the COVID-19 pandemic, protecting both themselves and the people using their services.

This scheme and the second part of PQS in 2020/21, which is being developed for the second half of the year, replace the original 2020/21 scheme that PSNC had agreed with the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I), and which, prior to the start of the pandemic, had been due to commence in April 2020.

Scheme requirements

To meet the requirements of the new scheme, contractors need to complete all 14 actions set out in a checklist, all of which relate to the response to the pandemic; many contractors will already have undertaken most if not all of the actions in the checklist over the last few months.

Download the Part 1 PQS 2020/21 Checklist for the COVID-19 response

PSNC has also developed the following support materials for contractors:

Funding and claims

The funding made available for the scheme is £18.75m and all contractors meeting the requirements can claim a payment of £1,630 via the NHSBSA’s Manage Your Service (MYS) portal.

Claims via MYS can be made between 14th July 2020 and 23:59 on 29th January 2021.

Any residual funding not paid to contractors within the Part 1 scheme will be distributed as part of payments in the Part 2 2020/21 scheme. Payments will be made by the NHSBSA as soon as possible after a claim has been submitted, with, for example, any claims submitted by 5th August 2020 being paid on 1st September 2020.

A few important points to note:

Any claims submitted by 5th August 2020 will be paid to contractors on 1st September 2020. Contractors submitting after 5th August 2020 will be paid in line with the payment schedule below:

 

Claim submitted by Paid to contractor
5th September 2020 1st October 2020
5th October 2020 1st November 2020
5th November 2020 1st December 2020
5th December 2020 1st January 2021
5th January 2021 1st February 2021
29th January 2021 (Closing Date) 1st March 2021

 

You have to claim for completion of the whole checklist – there is no payment for completing part of it

This Part 1 of PQS will be funded by £18.75m so each contractor that completes it will receive £1630

Details of Part 2 of PQS are expected soon (likely to start in October 2020) and will be funded by £56.25m. Any money from Part 1 PQS not claimed by contractors will be re-allocated into Part 2.

THE COMPLETION OF PART 1 PQS IS A GATEWAY REQUIREMENT TO PART 2 PQS


Part 2 PQS 2020/21

Part 2 of the scheme formally commenced on the 1st October 2020. This second part also focuses on the response to, and the recovery from, the pandemic. As we settle towards a new normal where COVID-19 remains in circulation, the PQS has been developed to incentivise quality improvement in areas that support the COVID-19 response by including criteria that improve patient safety and outcomes.

The full details were first published in the September 2020 Drug Tariff, however to support early contractor engagement, PSNC published an early view of the requirements on 6th August 2020. NHS England and NHS Improvement (NHSE&I) have now published guidance on the Part 2 Pharmacy Quality Scheme (PQS) 2020/21.

The remainder of the £75m PQS annual budget (£56.25m plus any unclaimed funding from the £18.75m attributed to PQS Part 1) will be applied to this scheme.

Contractors will receive a PQS payment if they have demonstrable evidence of meeting one or more of the 5 domains (please note, contractors must meet all of the quality criteria in each domain to be eligible for a PQS payment in respect of that domain). The overall level of the PQS payment will depend on how many of the domains the pharmacy declares that it meets.

The PQS must be claimed for between 09:00 on 4th February 2021 and 23:59 on 1st March 2021.

Completion of and claiming for the Part 1 scheme is a Gateway requirement for the Part 2 scheme.


Part 2 PQS Contractor Bandings Published

Pharmacy contractors will already be aware that a new approach to allocating the funding has been introduced in the Part 2 Pharmacy Quality Scheme (PQS) for 2020/21, with each domain having points allocated to it, but these varying dependent on the prescription volume of the contractor.

This change has been introduced to better recognise the varying workload and hence costs incurred by different contractors complying with the requirements of the scheme. While some costs will be common to contractors of all sizes, most of the elements of this new scheme involve variability of costs related to the number of staff employed at the pharmacy and staffing levels generally vary in relation to prescription volume.

Each PQS domain has a varying number of points dependent on the participating contractor’s total prescription volume in 2019/20.

So that contractors can be sure of which volume band they sit within the scheme, the NHSBSA has now published their allocation of contractors to the bands.

Click HERE to see which band your pharmacy falls within. Contractors can search, using the ODS code of their pharmacy, to view which banding they have been placed into. The bandings are based on the NHSBSA’s payment data for 2019/20. Any questions regarding the calculation of the bands can be sent to the NHSBSA Provider Assurance team at nhsbsa.pharmacysupport@nhs.net

For further guidance click here


Read the PQS Part 2 GMLPC Training Log

The GMLPC, in collaboration with Halton, St Helens and Knowsley LPC have prepared a summary to support you and your pharmacy team to complete the required training for PQS Part 2. Available here. We would encourage contractors and pharmacy teams to start planning to complete the training requirements early to manage the workload.

To support contractors the GMLPC have also produced a training tracker to help ensure all required staff complete all the necessary training for PQS Part 2. This resource is available here.


PQS Part 2 – GMLPC PCN Lead Information and Resources

GMLPC – Community Pharmacy PCN Lead Information

GMLPC PCN Lead Toolkit – PQS 2020-21

GMLPC PCN Lead Zoom call presentation


PQS Part 2 Templates

Training record sheet (Microsoft Word) to capture staff that have completed training.

Training record sheet (PDF)

Action plan template (Microsoft Word) to support the creation of any action plans required to meet the requirements of any PQS criteria.

Action plan template (PDF)

Weight Management – Data Collection Sheet  (Microsoft Word ) to capture data over a period of 4 consecutive weeks.

Weight Management – Data Collection Sheet  ( PDF )

Visit PSNC’s PQS hub  for more


PQS and service changes agreed to create extra capacity

NHS England and NHS Improvement (NHSE&I) and the Department of Health and Social Care (DHSC) have agreed to PSNC’s request for more flexible timings for completion of the work within the Pharmacy Quality Scheme (PQS) Part 2 2020/21 and the removal of some Community Pharmacy Contractual Framework (CPCF) requirements for 2020/21.

The following changes have been agreed to provide additional capacity for contractors to implement the Discharge Medicines Service on 15th February 2021 and to support the ongoing provision of key pharmacy services during the pandemic:

  • The PQS Part 2 2020/21 declaration will still take place as planned between 09:00 on 4th February 2021 and 23:59 on 1st March 2021, however, contractors will have until 30th June 2021 to complete any elements of the scheme they have declared as having met. Following their declaration, contractors will still receive any PQS payment due as part of the overall payment made by the NHSBSA to contractors on 1st April 2021;
  • Contractors are not required to complete an NHSE&I determined national clinical audit during 2020/21;
  • Contractors are not required to undertake a contractor chosen clinical audit during 2020/21;
  • Contractors are not required to undertake the Community Pharmacy Patient Questionnaire during 2020/21;
  • The Community Pharmacy Assurance Framework will not run in 2020/21, but this will run as normal in 2021/22; and
  • No action will be taken against contractors who have not completed the Data Security and Protection toolkit for 2019/20, provided they are working to complete the toolkit for 2020/21. Contractors have an extended deadline for completion of the 2020/21 toolkit, with submissions required by 30th June 2021.

Click here for more information


GMLPC – PQS 2020/21 Briefing

Pharmacy Quality Scheme 2020/21 – Part 1

This GMLPC briefing has been created to help support Community Pharmacy Contractors in GM achieve part 1 of the Pharmacy Quality Scheme 2020/21. We have broken down the 14 required steps of part 1, into manageable activities and have provided relevant supporting resources.

The information below is also available in PDF format here

 

1)Pharmacy Premises Risk Assessment

1a) The contractor has conducted a COVID-19 infection control risk assessment for the pharmacy premises and where risks have been identified, has implemented mitigating actions, e.g. physical barriers such as above head height protective screens, where possible and appropriate.

To achieve this criterion please ensure you have completed one of the risk assessments below and ensure you have an up to date copy available.

There are a variety of risk assessment tools that contractors can use to assess their premises and their procedures.
Risk assessment templates and guidance are available from:

For further information and resources on risk assessments please visit the GMLPC COVID-19 Resources page here


1b) The contractor has made appropriate adjustments to maximise social distancing in accordance with the latest government guidance on COVID-19 secure workplaces: Working safely during coronavirus

Following the completion of the risk assessment criteria set out in 1a, please review any risks identified regarding social distancing. Reasonable adjustments will need to be made to ensure your pharmacy is complying with the guidance set out in the Working safely during the coronavirus guide.

To implement this consider keeping evidence, such as, action plans, pictures of any physical changes made in response to the action plan and staff training records.

PSNC has published a risk assessment template that will help pharmacy teams to identify further potential changes which could be made to their pharmacy environment or procedures during the pandemic to increase the safety of staff and patients.

The Community Pharmacy Patient Safety Group has developed guidance on the safe use of consultation rooms during the pandemic, to help pharmacy teams consider how they can minimise risk when using them: Safe use of consultation rooms: COVID-19

 


2) Standard Operating Procedures (SOPs)

The contractor has updated the pharmacy Standard Operating Procedures (SOPs) or related guidance, where appropriate, to minimise the risk of transmission of SARS-CoV-2, having considered the guidance within the latest NHSE&I COVID-19 Pharmacy SOP. All staff have been briefed on changes relevant to their role in the pharmacy and a record of this is maintained.

In order to achieve this criterion, contractors are required to evidence the fact that they have updated or amended their SOPs in order to minimise the risks associated with COVID-19, in line with the guidance from the current NHSE&I COVID-19 Pharmacy SOP.

Contractors may wish to create a list or summary of SOP amendments as well as a record showing that staff have been briefed about these changes and have been given the necessary support and/or training to implement them in the pharmacy.

A staff briefing record sheet has been created by PSNC to enable contractors to easily document any briefing or training that has taken place.

Other useful guidance

The Royal Pharmaceutical Society (RPS) has a page which collates important information and updates for pharmacists, including contingency planning and FAQs.

Public Health England has also produced a flow chart for management of suspected COVID-19 cases

Further resources and contractor guidance have also been collated by PSNC.


3) Display Information

3a) The contractor has appropriate and up to date COVID-19 posters, warnings and information displayed so they are visible at entry points to the pharmacy premises.

In order to achieve this criterion, contractors may consider taking photographs of current posters published by Public Health England and other relevant sources on display at entry points to their pharmacy.

To assist with this, PSNC has compiled a list of up to date posters and other materials from a range of relevant sources. Contractors can use this page to locate key materials referring social distancing and the use of PPE to print and display on their premises.

GMLPC have also produced a range of posters for display. These can be found within the GMLPC Resources for Contractors section of our COVID resources page.

Additional materials and resources have also been published by Public Health England available here


3b) For Distance Selling Pharmacies, there are appropriate and up to date COVID19 warnings and information displayed prominently on their website.

In order for Distance Selling Pharmacies to achieve this criterion they should download and publish any relevant resources from the NHS Resources Hub onto their website.

Contractors should consider saving screenshots of their website pages on which these posters and information are displayed prominently for visitors. The resources displayed to patients may include the following key information:

  • Don’t enter your local pharmacy if you or anyone you live with has coronavirus symptoms;
  • There’s no need to order extra medicines

4) Staff Risk Assessments

Members of staff have been informed of risk factors for poorer outcomes of COVID-19 such as gender, age, BAME and comorbidities. Individual COVID-19 risk assessments have been offered to all members of staff. Where the staff members accepted the offer, the contractor has conducted an individual risk assessment for each member of staff and put in place any appropriate mitigations. A record of this is maintained.

To achieve this criterion please ensure you have a copy of individual risk assessments or waivers on file and you have evidence of actions taken to mitigate risks identified.

All Pharmacy contractors will have received a letter from the BSA to complete a declaration confirming that a risk assessment has been completed for all staff.

Community Pharmacy contractors are being asked to declare their progress in performing COVID-19 risk assessments for staff by completing the NHSBSA snap survey which has been sent to you with a unique link via your NHSmail account.

The next window to declare your progress will be starting at 9am on 24th July to 11.59pm on 31st July.

GMLPC, Bolton LPC and the CPPB have worked in partnership with the GMHSCP to develop a BAME risk assessment tool in Greater Manchester.

The recently published Public Health England report confirms that people from Black, Asian and Minority Ethnic (BAME) backgrounds are being disproportionately affected by COVID-19. Therefore, community pharmacy teams should continue to risk assess all staff, particularly those who may be at increased risk.

The link to the BAME Risk Assessment tool as well as other reputable risk assessment tools can be found below

Contractors have a choice to use whichever risk assessment they think is appropriate.


NHSE&I have shared the following resources which may assist:

NHS England and NHS Improvement (NHSE&I) held a webinar on risk assessments in community pharmacy. Aiming to help and support community pharmacy employers and managers to carry out the requested staff risk assessments within the given time frame, the webinar included speakers from the National Pharmacy Association and Royal Pharmaceutical Society.

The webinar recording and slides have now been published on the Future NHS website (login required, but it is free to register).

GMLPC website – Useful links


5) Staff COVID Testing Referral

The contractor has a process in place to advise and refer staff with symptoms of COVID-19 for testing in accordance with Government guidance

To complete this criterion, contractors may consider providing evidence that they have produced briefing document or notification for staff containing information about the process of referring staff with symptoms of COVID-19 for testing in accordance with government guidelines. They can also keep a record of where the most up to date information can be found and share this with their staff.

A staff briefing record sheet has been created by PSNC to enable contractors to easily document any briefing or training that has taken place.

The information and government guidelines may be subject to change. Thus, it is imperative that any advice compiled for staff is reviewed and amended if/when necessary to ensure that it remains in line with government guidelines.

The government currently advise anyone to take a test within the first 5 days of having coronavirus symptoms. There are two main types of swab tests available to check if you currently have coronavirus.

You can choose to take the test:

  • at a test site nearby
  • using a home test kit

Both types of tests can be booked using the government portal.

PSNC has also created a page with information on how pharmacy team members can access testing for COVID-19.


6) Hygiene

6a) The contractor has available facilities and resources (e.g. alcohol handrub) to support staff to conduct hand hygiene procedures frequently, to reduce the transmission risk of SARS-CoV-2 and support infection control.

In order to achieve this criterion, contractors should have sufficient hand sanitiser or hand-rub available to ensure that all staff are able to frequently wash their hands. To evidence this you may wish to take photographs of where hand sanitisers are positioned within the pharmacy.


6b) The contractor has posters displayed in relevant areas to promote best hand hygiene practice. Example shown here

To achieve this criterion contractors should clearly display posters within the pharmacy which promote good hand hygiene and provide guidance to staff and patients about how to thoroughly wash their hands.

Current guidance advises that you should wash your hands for 15-20 seconds to ensure they are washed thoroughly.

Public Health England have published a poster detailing the step by step process for washing hands. You may wish to display this in your pharmacy.

Contractors may wish to take photographs of this and other relevant posters on display in relevant areas, to evidence that they have met this criterion.


6c) The contractor has posters displayed in relevant areas to promote best practice use of handrub. Example shown here

To achieve this criterion contractors should clearly display posters within the pharmacy which promote best practice in relation to using handrub or sanitiser to wash hands.

Public Health England has published a poster containing instructions on how handrub should be used.

Contractors may wish to take photographs of this and other relevant posters on display in relevant areas such as alongside sanitiser, to evidence that they have met this criterion.


7) PPE Provisions

The contractor has reviewed and adopted, as a minimum, the PPE recommendations, for their staff working in the pharmacy.

To complete this criterion pharmacies at a minimum must provide their pharmacy team with Fluid-resistant (Type IIR) surgical masks when they will be working in an area with possible or confirmed case(s) and unable to maintain 2 metres social distance. However, we would encourage pharmacies to implement as many recommendations as they deem necessary to protect their staff and patients. e.g. disposable gloves, disposable plastic apron and disposable fluid-repellent coverall/gown.

PSNC have compiled a large number of resources and information on the use of personal protective equipment (PPE) to protect workers during the COVID-19 pandemic on a dedicated page. Available here

The page covers topics such as;

  • Use of PPE in community pharmacies
  • Supplies of PPE to community pharmacies
  • Expiry dates of PHE provided PPE
  • NHSE&I/PHE updates on PPE
  • Installing protective screens in pharmacies
  • Social Distancing and Infection Control Risk Review
  • Facemasks and face coverings

GMLPC and Bolton LPC have been working to access PPE for contractors locally in Greater Manchester. We would advise contractors to take the following steps to access PPE:

Please contact your wholesaler in the first instance.

If you cannot get PPE from your wholesaler, please complete the following form.

As a final resort, an urgent request can be made via the national NSDR helpline by telephoning 0800 915 9964.

For further information click here


8) Business Continuity plan

The contractor has reviewed and, as appropriate, updated business continuity plans for the COVID-19 pandemic including Emergency Business Continuity Planning for any potential closure(s), identifying one or more local pharmacies, which can support and provide pharmaceutical services to their patients, whilst the pharmacy is closed

To complete this criterion Pharmacy teams must ensure they have Copies available of their up to date Business Continuity plan reflecting plans for COVID-19 interruptions.

Emergency and Business Continuity Planning templates

All businesses and NHS providers, including community pharmacy contractors, need to have an ability to cope with emergency situations, so that wherever possible, they can continue to provide services to patients and the public.

PSNC has updated its hub for community pharmacy teams on the COVID-19 coronavirus to include new business continuity guidance and details of measures to support contractors.

Advice and information on shared care clients, nursing and care home patients, and providing Multi-compartment Compliance Aids (MCAs) has been added to the business continuity section of the hub.

These documents have been drafted to help pharmacies assess their business mix and decide how they can improve their dispensary efficiency, whilst still supporting their most vulnerable patients, in the event of multiple members of staff being off work to COVID-19.

Business Continuity Plan Template

PSNC and GMLPC has developed the following business continuity plan templates for use by contractors; this includes planning for business continuity during periods of disruption to IT services

Pharmacy Business Continuity Plan template

Pharmacy Business Continuity Plan checklist

GMLPC Business Continuity Plan template

Further Resources available from PSNC are available here

Test and Trace – business continuity planning

Actions that NHS providers should take to help support Test and Trace. NHSE&I has asked all primary care contractors – including community pharmacy contractors – to take the following actions:

  • To prepare for potential staff absence, providers should review their existing business continuity plans and take actions as required. This includes ensuring that arrangements are in place within a primary care network or between buddies to maintain patient access to services.
  • Providers should inform their commissioner as soon as they consider that delivery of the full contracted service may be compromised by staff absence due to Test and Trace. The commissioner will work with the contractor to put business continuity arrangements in place and to maintain access to services for patients. The provider will need to update information on patient accessible websites and the impacted NHS 111 Directory of Services profiles will need to be updated.
  • The commissioner will inform the Regional Incident Coordination Centre without delay and work with the provider to implement appropriate business continuity measures. The Regional Team will notify the National Incident Coordination Centre.

Read NHSE&I’s letter on minimising nosocomial infections in the NHS

An increase in cases in Greater Manchester increases the likelihood that a member of your pharmacy team will contract COVID-19 and therefore the pharmacy be contacted by Test and Trace.

Since the launch of the Government’s NHS Test and Trace programme, a number of pharmacy teams across England have been asked to self-isolate in accordance with the service.

GMLPC suggest that contractors read the PSNC Briefing 022/20: NHS Test and Trace – Key points for contractors as Q&As. This briefing provides further information on the programme, gives advice on patient and staff contacts, and outlines the relevant mitigations that may help to avoid the need for whole pharmacy teams to self-isolate if one member tests positive for COVID-19.

GMHSCP has now published Test and Trace programme guidance for Community Pharmacy with input from the Community Pharmacy Provider Board. Please see here for the test and trace guidance for GM.

If your pharmacy is impacted by Test and Trace please inform GMLPC by emailing enquiries@gmlpc.org.uk

Management of outbreaks – minimising the risks

Contractors need to consider COVID related risks to staff and patients and put in mitigations, and may wish to refer to PSNC’s Social Distancing and Infection Control Risk Review Template (this is available here.

This recently published template provides suggestions on how contractors can reduce the risk of infection and maintain 2m social distancing and it will be reviewed and updated by PSNC as required.

Further support can be found on the business continuity and network resilience pages of PSNC’s COVID-19 hub, as well as more general guidance on our Emergency and Business Continuity Planning page.

The RPS has also information on protecting your team in the pharmacy.

The GMLPC also has a wide variety of resources available here

Use of face masks

This update was published on the 24th July 2020. Public Health England (PHE) has updated its guidance on the wearing of facemasks in primary and community health care settings. In summary, the recommendation is that all pharmacy staff now wear facemasks, unless the pharmacy is COVID-19 secure, including all staff being able to maintain a social distance from one another.

This aligns the PHE guidance with PSNC’s guidance to contractors, issued in mid-June.

Read the updated PHE guidance

The recommendation is for a Type l or Type ll face mask to be worn to prevent the spread of infection from the wearer. If Type IIR face masks are more readily available, and there are no supply issues for their use as personal protective equipment, then these can be used as an alternative to Type I or Type II masks.

The extended use of face masks does not remove the need for other measures to help to protect staff, patients and the public and contractors should ensure that all appropriate and relevant steps continue to be taken to make the pharmacy COVID-19 secure.

Please ensure you keep up to date with the latest guidance, which will be posted on PSNC


9) Patient Isolation

The contractor has identified an area of the pharmacy where symptomatic patients could be isolated if they are unable to leave the premises, e.g. if an ambulance is required, and can follow the process outlined in the latest COVID19 Pharmacy SOP (including decontamination of the identified area after the symptomatic patient has left).

To achieve this criterion, it is recommended that a record sheet detailing the names of members of staff who have been briefed on the actions to take if a symptomatic patient presents in the pharmacy and the specified location for isolation. It is recommended staff have signed and dated this to confirm they have been briefed.

Preparation of your pharmacy

Identify at least one suitable space/room in the pharmacy for patient/patient group isolation. If there is no suitable isolation room, identify an isolated area within the pharmacy that can be cordoned off and maintains a 1-metre space from other patients and staff. De-clutter and removal of non-essential furnishings and items: this will assist if decontamination is required post-patient transfer. If possible, retain a telephone in the room for remote assessment. Place a card/sign in the isolation room/area with pharmacy contact details, e-mail, telephone numbers, pharmacy location and post code, include the name of the lead pharmacist in attendance (this information is to be available to the patient when they contact NHS 111).

  • Brief all staff on the potential use of the rooms/areas and actions required if the event that it is necessary to vacate rooms/areas at short notice.
  • Prepare appropriate space/room signage to be used if the space/room is occupied.
  • Prepare a patient ‘support pack’ (to be held in reserve) that may include, items such as bottled water, disposable tissues, clinical waste bag.
  • Review the isolation space/area and consider the options for carrying out regular checks on the general welfare of the isolated patient/patient group. This may be simply a knock and conversation through the closed door or could be verbal and/or visual contact via remote means, e.g. telephone, Skype/FaceTime, pharmacy intercom, baby monitor. Waste such as PPE, used tissues and disposable cleaning cloths can be stored securely within disposable rubbish bags. These bags should be placed into another bag, tied securely and kept separate from other waste. This should be put aside for at least 72 hours before being put in your usual external waste bin

Pharmacy preparation for incident management

Pharmacies may wish to draw on their existing protocols for dealing with medical emergencies in the pharmacy, the incident management principles are the same:

  • Develop and rehearse the practice’s COVID-19 triage protocols and isolation procedures: agree practice approach for each stage of the potential scenarios confirm role and responsibilities for each member of staff confirm lead for discussions with patients/NHS111 prepare an aide-mémoire for staff (using guidance in Section 3) and rehearse the pharmacy response.
  • Review the coronavirus infection prevention and control protocols here
  • Anticipate impacts on pharmacy schedule. Pharmacies are advised to consider reviewing the likelihood of disruption to services and prioritise the most urgent pharmaceutical service work required on the day. Review the pharmacy’s business continuity plan. PSNC have provided examples of a comprehensive business continuity plan and checklist. Coronavirus specific business continuity guidance is also available on the NPA website.

Decontamination

  1. Cleaning and decontamination should be carried out in line with the government guidance.
  2. If pharmacies need to close temporarily for cleaning of communal areas, usual business continuity arrangements should be followed.
  3. Pharmacies should otherwise remain open unless advised to close by the health protection team.

Remote consultations should be used wherever possible to minimise risk of transmission.

The government advice regarding shielding and self-isolation must be followed by staff as well as patients. Staff at risk may be able to provide services remotely or from a non- public area. Risks to individual staff should be assessed on an ongoing basis


10) Good Practice

The contractor has reviewed examples of good practice during the pandemic and has adopted them as considered appropriate for the individual pharmacy. These include examples collated by the GPhC

To achieve this criterion the pharmacy must have a record of examples reviewed, and any actions agreed to implement changes in the pharmacy to support their introduction.
There is no minimum requirement, but contractors are advised to use the examples on the GPhC website to learn from others and to continuously improve outcomes for people using their pharmacy services.
Examples of good practice can be drawn from pharmacy assessments conducted throughout this process.


11) Covid-19 Guidance

The contractor and registered staff working at the pharmacy have read relevant COVID-19 guidance on the GPhC website and a record of this is maintained.

To meet this criterion a record sheet detailing the relevant COVID-19 guidance which has been read by named GPhC registered members of staff. It is recommended that the GPhC registered staff sign and date the record once they have read the guidance.

Please click here for the Pharmacy Quality Scheme: Staff briefing record sheet


Pharmacy Quality Scheme 2020/21 – Part 2

Part 2 of the scheme formally commenced on 1st October 2020. This second part also focuses on the response to and the recovery from the pandemic. As we settle towards a new normal where COVID-19 remains in circulation, the PQS has been developed to incentivise quality improvement in areas that support the COVID-19 response by including criteria that improve patient safety and outcomes.

The full details were first published in the September 2020 Drug Tariff, PSNC published an early view of the requirements, to support early contractor engagement with the scheme on 6th August 2020. NHS England and NHS Improvement (NHSE&I) have now published guidance on the Part 2 Pharmacy Quality Scheme (PQS) 2020/21.

The GMLPC briefing below has been created to help support Community Pharmacy Contractors in GM achieve part 2 of the Pharmacy Quality Scheme 2020/21.

 

Domain 1 – Infection Prevention and Control and Antimicrobial Stewardship

To minimise nosocomial infections in the NHS, several measures need to be adopted. These include the use of non-pharmaceutical interventions, such as social distancing, as well as ongoing, consistent implementation of national infection prevention and control guidance. Such measures are paramount in reducing the transmission of COVID-19 as well as all healthcare associated infections.
Contractors must meet both quality criteria listed below in the Infection Prevention and Control and Antimicrobial Stewardship Domain to be able to claim payment for this domain.

Infection Prevention and Control

The aim of this criterion is to reduce the risk of transmission of COVID-19 within community pharmacies and potential harm caused by the pandemic by increasing awareness and implementing actions following training to improve infection prevention and control practices.

Requirements

All non-registered pharmacy staff working at the pharmacy must complete the HEE Infection Prevention and Control Level 1 e-learning and assessment
All registered pharmacy professionals must complete the HEE Infection Prevention and Control Level 2 e-learning and assessment

This training must have been successfully completed between 1 January 2020 and the day of the PQS 2020/21 Part 2 declaration.

Following the completion of the training, all of the pharmacy team working at the pharmacy must have completed a team review, documenting the reflections and actions following the training, and amending standard operating procedures (SOPs) and associated guidance, where appropriate.

  • Exemptions* – Newly joined / Returning staff
  • Certification*

Submitted to NHS England & NHS Improvement on the MYS application

· The total number of non-registered staff who have satisfactorily completed the Level 1 e-learning and assessment.

· The total number of registered staff who have satisfactorily completed the Level 2 e-learning and assessment.

· A declaration that they have completed the team review.


Antimicrobial Stewardship

The aim of this criterion is to reduce the potential harm caused by antimicrobial resistance (AMR) through the promotion of antimicrobial stewardship activity in community pharmacy.

Requirements

All patient facing pharmacy staff that provide advice on medicines or health care must complete the PHE Antimicrobial Stewardship for Community Pharmacy e-learning and e-assessment

In addition, contractors must have available, at premises level, an antimicrobial stewardship action plan for the pharmacy, which details how they will promote AMS. The action plan must demonstrably include details of how all pharmacy staff involved in the provision of self-care advice will incorporate the principles of AMS into selfcare advice, including reinforcing the messages around appropriate use of antibiotics, and the uptake of vaccinations, including the influenza vaccination. All patient facing staff that provide health advice, should also become antibiotic guardians, if they have not already done so, and have an awareness of the local antibiotic formulary.

 

There must be documented evidence, at the pharmacy, that the actions within the plan have been implemented by the day of the declaration.

  • Exemptions* – Newly joined / Returning staff
  • Certification*

Submitted to NHS England & NHS Improvement on the MYS application

· The total number of staff who have satisfactorily completed the training and assessment.

· A declaration they have completed an antimicrobial stewardship action plan for the pharmacy.

· A declaration that all patient facing staff that provide health advice, have become antibiotic guardians and have an awareness of the local antibiotic formulary.

Exemptions*

Newly joined / Returning staff – Pharmacy contractors can count them as having completed the training as long as a training plan has been implemented guaranteeing training and assessment completion within 30 days of the declaration. This training plan and demonstrable evidence of completion of training and assessment, within 30 days of the day of the declaration, must be retained at the pharmacy to demonstrate that the pharmacy contractor has met this quality criterion.

Certification*

An electronic certificate of completion of the training will be provided following the completion of the assessment. Contractors must keep a copy of the certificate for each member of staff as evidence that the training has been completed. On the day of the PQS 2020/21 Part 2 declaration, the contractor must have for each staff member, excluding those staff for whom there is a training plan in place as described above, at premises level, a copy of the personalised certificate provided upon completion of the training and assessment, as evidence that all members of staff have completed the training.

Domain 2 – Prevention

The COVID-19 pandemic has identified risk factors and inequalities that have resulted in poorer patient outcomes for those who have contracted the disease. There is therefore renewed focus on tackling modifiable risk factors such as obesity as well as mental health.
Contractors must meet all three quality criteria listed below in the Prevention Domain to be able to claim payment for this domain.

Suicide Awareness and Action Plan

The aim of this criterion is to contribute towards prevention of suicide by enabling all community pharmacy patient facing staff to appropriately discuss suicide with anyone who either raises that they are having suicidal thoughts, or is displaying behaviours that prompt pharmacy staff to start a conversation on this matter.

Requirements

Patient-facing staff working at the pharmacy must have completed the Zero Suicide Alliance (ZSA) training
Once all members of the team, who do not fall under the exemptions, have completed the training, a suicide prevention action plan should be prepared which includes the action to take if anyone reports to staff that they have suicidal feelings. The action plan must include making some demonstrable recorded changes such as compiling resources to provide to people who require support. Where a contractor already has a suicide prevention action plan in place created prior to this year’s PQS, it should be reviewed to ensure that any information provided to patients remains up to date. Any changes to the plan that had been made as a result of the training and activities undertaken as part of this year’s PQS must be documented and retained as evidence of having met the declaration.
  • Exemptions* – Newly joined / Returning staff / Staff affected by suicide
  • Certification*

Submitted to NHS England & NHS Improvement on the MYS application

· The total number of staff who have satisfactorily completed the training.

· The total number of staff that have not completed the training under the above exemption.

· A declaration they have completed, or updated, a team action plan.


Sugar Sweetened Beverages

The aim of this quality criterion is to support community pharmacies in creating an environment conducive to healthy living and to align with the NHS standard contract requirements in helping both staff and the public avoid sugar sweetened beverages.  This quality criterion builds on the training on Children’s oral health, which was introduced, in the 2018/19 Quality Pharmacy Scheme and supports the aims of the weight management criterion in this scheme.

Requirements

Sales by the pharmacy (the registered pharmacy premises) of Sugar Sweetened Beverages must account for no more than 10% by volume in litres of all beverages sold.
Suggested forms of evidence can include, but are not limited to, pharmacy planograms that show intended stock levels, sales data held by pharmacy contractors and/or till receipts. Where pharmacy contractors are part of a larger retail store (eg a supermarket), they should have discussions with the supermarket within which they are based in to explore arrangements so that the pharmacy is not routinely required to sell SSBs through their tills.

Submitted to NHS England & NHS Improvement on the MYS application

· A declaration regarding whether or not the pharmacy sells sugar-sweetened beverages.

· A declaration that sugar sweetened beverages, if sold by the pharmacy, account for 10% or less of all beverages sold.


Weight management

The aim of this criterion is to prevent ill health by raising awareness with pharmacy service users of the impact of weight and waist circumference on health and the relevance of body mass index (BMI) to their overall health and wellbeing.

Requirements

All non-registered patient-facing pharmacy staff that provide health promoting advice must have completed the PHE All Our Health bitesize training and assessments on Adult Obesity and Childhood Obesity
On the day of the declaration, 80% of registered pharmacy professionals working at the pharmacy must have satisfactorily completed sections 1 and 3 of the CPPE Weight management for adults: understanding the management of obesity training and assessment available on the CPPE website

Pharmacy teams are also required to have completed an action plan of how they would proactively engage with people to discuss weight and assist a person who would like support with their weight.

The action plan must include, but should not be limited to, a list of local support or physical activity groups that the person could be referred to and support materials/tools they could use.

Pharmacy teams are encouraged to review the Public Health England Let’s Talk About Weight infographic and the Let’s talk about weight: a step-by-step guide to brief interventions with adults for health and care professionals guidance for support with initiating and managing conversations with people about weight management.

If a person that would like support with their weight is identified, a competent individual within the pharmacy (e.g. registered pharmacy professional or nominated team member/qualified health champion) must guide the person on how to measure their Body Mass Index (BMI), using an appropriate BMI calculator such as the NHS healthy weight calculator and advise them on how to measure their waist circumference.

The advice to the person should include explaining the purpose of measuring BMI and waist circumference. Pharmacy teams must be able to calculate BMI from measurements given to them by individuals seeking support with their weight, and support those who wish to lose weight with advice and referral to other sources of support, where appropriate.

The above advice could be provided in the pharmacy or via remote means, such as video consultations, where that is appropriate for the requirements of the individual.

On the day of the declaration, the pharmacy team has recorded, over a period of 4 consecutive weeks, the total number of people who:

· had a conversation with a trained member of the pharmacy team about the benefits of achieving a healthy BMI and who have been shown how to self-measure and calculate their BMI and self-measure their waist circumference; and

· were referred to other services for weight management support, e.g. physical activity.

  • Exemptions* – Newly joined / Returning staff
  • Certification*

Submitted to NHS England & NHS Improvement on the MYS application

· The total number of non-registered, patient facing pharmacy staff that have satisfactorily completed the PHE All Our Health: bitesize training and assessments on Adult Obesity and Childhood Obesity.

· The total number of registered professionals that have satisfactorily completed sections 1 and 3 of the CPPE Weight management for adults: understanding the management of obesity training and assessment.

· A declaration that they have completed a weight management action plan on how they would assist a person who would like support with their weight.

· The total number of people who had a conversation, over a period of 4 consecutive weeks, with a trained member of the pharmacy team about the benefits of achieving a healthy BMI and who have been shown how to self-measure and calculate their BMI and self-measure their waist circumference.

· The total number of people referred to other services for weight management support, e.g. physical activity.

Exemptions*

Newly joined / Returning staff – Pharmacy contractors can count them as having completed the training as long as a training plan has been implemented guaranteeing training and assessment completion within 30 days of the declaration. This training plan and demonstrable evidence of completion of training and assessment, within 30 days of the day of the declaration, must be retained at the pharmacy to demonstrate that the pharmacy contractor has met this quality criterion.

Staff affected by suicide – Staff members, who have been affected by suicide and do not wish to undertake the ZSA training, are exempt from completing it. This situation will need to be dealt with sensitivity.

Certification*

An electronic certificate of completion of the training will be provided following the completion of the assessment. Contractors must keep a copy of the certificate for each member of staff as evidence that the training has been completed. On the day of the PQS 2020/21 Part 2 declaration, the contractor must have for each staff member, excluding those staff for whom there is a training plan in place as described above, at premises level, a copy of the personalised certificate provided upon completion of the training and assessment, as evidence that all members of staff have completed the training.


Domain 3 – Risk Management

This domain and its requirements links to the ongoing NHS priority to continually improve patient safety as outlined in the NHS England & NHS Improvement Patient Safety Strategy.

The aim here is to support contractors to add to and reflect on the work they have done in relation to this in previous years. All pharmacy professionals should understand their professional practice and how to identify, review, assess and mitigate against these risks in the pharmacy.

Requirements – for contractors who completed a risk review as part of the Risk management and safety domain for the 2019/20 PQS

Requirements – for contractors who DID NOT complete a risk review as part of the Risk management and safety domain for the 2019/20 PQS

80% of all registered pharmacy professionals working at the pharmacy must have satisfactorily completed the CPPE risk management training and e-assessment. If the training and assessment were satisfactorily completed between 1st April 2018 and 31st March 2020, this does not need to be repeated in 2020/21. 80% of all registered pharmacy professionals working at the pharmacy must have satisfactorily completed the CPPE risk management training and e-assessment. If the training and assessment were satisfactorily completed between 1st April 2018 and 31st March 2020, this does not need to be repeated in 2020/21.

The pharmacy must have available, at premises level, a new risk review or an update of the previous risk review undertaken as part of the PQS 2019/20. This new or updated review must include a recorded reflection on the risk of missing sepsis identification and the risk minimisation actions that the pharmacy team has been taking and any subsequent actions identified as a result of the reflection.

The risk review should also include the risk of missing red flag symptoms during OTC consultations and contractors should record demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

These actions may include, reviewing staff training records, observing over the counter advice being provided to patients, identifying any gaps in knowledge or capability for pharmacy team members, conducting a team discussion focusing on identifying common danger signs and symptoms and knowing how to manage these, including when to refer patients.

The pharmacy must have available, at premises level, a new risk review or an update of the previous risk review undertaken as part of the PQS 2019/20. This new or updated review must include a recorded reflection on the risk of missing sepsis identification and the risk minimisation actions that the pharmacy team has been taking and any subsequent actions identified as a result of the reflection.

The risk review should also include the risk of missing red flag symptoms during OTC consultations and contractors should record demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

These actions may include, reviewing staff training records, observing over the counter advice being provided to patients, identifying any gaps in knowledge or capability for pharmacy team members, conducting a team discussion focusing on identifying common danger signs and symptoms and knowing how to manage these, including when to refer patients.

Exemptions* – Newly joined / Returning staff

Certification*

80% of all registered pharmacy professionals working in the pharmacy have satisfactorily completed the CPPE sepsis online training and assessment and must be able to demonstrate that they can apply the learning to respond in a safe and appropriate way when it is suspected that someone has sepsis.

Submitted to NHS England & NHS Improvement on the MYS application

They must have demonstrable evidence that all patient-facing staff have understood the alert symptoms to ensure referral of suspected sepsis to a pharmacist.

. The total number of registered pharmacy professionals working at the pharmacy who have satisfactorily completed CPPE Risk management training and e-assessment.

. A declaration that they have updated a risk review on the risk of missing sepsis identification and have recorded demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

. A declaration that they have completed a new risk review on the risk of missing red flag symptoms during over the counter consultations and have recorded demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

Exemptions* – Newly joined / Returning staff

Certification*

Submitted to NHS England & NHS Improvement on the MYS application

. The total number of registered pharmacy professionals working at the pharmacy who have satisfactorily completed CPPE Risk management training and e-assessment.

· The total number of registered pharmacy professionals working at the pharmacy who have satisfactorily completed CPPE sepsis online training and e-assessment.

· A declaration that they have completed a new risk review on the risk of missing sepsis identification and have recorded demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

. A declaration that they have completed a new risk review on the risk of missing red flag symptoms during over the counter consultations and have recorded demonstrable risk minimisation actions that have been undertaken to mitigate this risk.

Exemptions*

Newly joined / Returning staff – Pharmacy contractors can count them as having completed the training as long as a training plan has been implemented guaranteeing training and assessment completion within 30 days of the declaration. This training plan and demonstrable evidence of completion of training and assessment, within 30 days of the day of the declaration, must be retained at the pharmacy to demonstrate that the pharmacy contractor has met this quality criterion.

Certification*

An electronic certificate of completion of the training will be provided following the completion of the assessment. Contractors must keep a copy of the certificate for each member of staff as evidence that the training has been completed. On the day of the PQS 2020/21 Part 2 declaration, the contractor must have for each staff member, excluding those staff for whom there is a training plan in place as described above, at premises level, a copy of the personalised certificate provided upon completion of the training and assessment, as evidence that all members of staff have completed the training.

Domain 4 – Primary Care Network – Prevention (Flu Vaccination Service)
Domain 5 – Primary Care Network – Business Continuity

Over the last couple of months, Greater Manchester LPC has been working tirelessly behind the scenes to ensure contractors are fully supported to achieve the Pharmacy Quality Scheme (PQS) 2020/21 Part 2 domains. In this years PQS Part 2, two out the five domains relate explicitly to Primary Care Network engagement, more specifically:

  • Domain 4 – Primary Care Network – Prevention (Flu Vaccination Service)
  • Domain 5 – Primary Care Network – Business Continuity

A detailed support briefing has been developed by the LPC to ensure contractors feel supported to understand what is required of them, along with the PCN leads, to achieve these criterion. The briefing has been circulated to you and the Community Pharmacies within your network via your Primary Care Network email hub (using your NHS Shared Mailbox).

Actions…

  • Please check your NHS Shared Mail Box for the contractor support briefing.
  • Please ensure that you and your team are regularly checking your NHS shared mail accounts and you have a robust process that ensures the regular review and monitoring of this inbox.

All-important communications and updated guidance relating to PCNs will be communicated via this channel. A copy of the briefing can also be found here

As always, if you require any further help with Primary Care Network engagement, please contact Rikki Smeeton – Senior Responsible Officer Primary Care Network Engagement at: Rikki.smeeton@gmlpc.org.uk

PQS Part 2 – GMLPC PCN Lead Information and Resources

GMLPC – Community Pharmacy PCN Lead Information

GMLPC PCN Lead Toolkit – PQS 2020-21

GMLPC PCN Lead Zoom call presentation


PQS: Preparing to declare – additional FAQs

As the declaration window for the Pharmacy Quality Scheme (PQS) 2020/21 Part 2 approaches, PSNC has received several related to the announced flexible timing agreed with NHS England and NHS Improvement (NHSE&I) and the Department of Health and Social Care (DHSC). PSNC have confirmed some additional questions and answers with NHSE&I that will assist contractors in preparing to make their declarations.

Find further information on completing your declaration in the next section below. 

Background and general

Q. Will all elements of PQS be extended until 30th June 2021?

No. The PQS Part 2 2020/21 declaration will still take place as planned in February 2021 however, contractors will have until 30th June 2021 to collate the evidence to demonstrate that they are compliant with any elements of the scheme they declared as having met in Domain 1 – Infection Prevention & Control and Antimicrobial Stewardship, Domain 2 – Prevention and Domain 3 – Risk management.

Domain 4 – Primary Care Network (PCN) – Prevention aimed to reduce the risk of harm resulting from contracting the influenza virus for all patients aged 65 and over and as a result, to reduce pressure on the NHS during winter. The domain incentivised collaboration of community pharmacy and general practice (through the PQS and the Impact and Investment Fund (IIF) respectively), to work together to increase the number of eligible people vaccinated.

The domain required engagement with the Pharmacy PCN Lead to confirm involvement in increasing the uptake of flu vaccines in the over 65s. Leads could then confirm to the PCN how community pharmacies in the PCN would collaborate to increase vaccine uptake during the data capture period between 1st September 2020 to 31st January 2021. Engagement with the PCN needed to occur within the data capture period to be considered as collaboration towards a shared target. Therefore, this domain cannot be extended beyond this point, as activity should have already largely finished.

Only contractors that engaged with the Pharmacy PCN Lead to confirm they would be involved in increasing the uptake of flu vaccination to patients aged 65 by provision of vaccinations and where subsequently the Pharmacy PCN Lead engaged with the PCN Clinical Director or appointed representative to share these plans, can seek to declare against this domain.

Domain 5 – Primary Care Network – Business continuity requires participation in a contractor discussion and for the Lead to collate the information to share with all contractors within the PCN, the PCN, the Local Pharmaceutical Committee (LPC) and NHS England and NHS Improvement (NHSE&I). NHSE&I have agreed that collating the evidence to demonstrate that they are compliant with this domain can be extended until 30th June 2021 provided the contractor discussion has been undertaken before the end of the declaration period. The Pharmacy PCN Lead must also have received confirmation from all contractors aligned with the PCN that intend to declare against this domain that they will actively participate in any additional work required to meet the requirements of the domain. The Pharmacy PCN Lead must have received this confirmation from contractors wishing to declare for this domain before the end of the declaration period, to allow the Lead to declare all participating contractor ODS codes in their declaration.

For both domain 4 and domain 5, if activity has already occurred, PSNC guidance to contractors does indicate that where the Pharmacy PCN Lead has made reasonable attempts to contact contractors three times, by two different methods and the contractor has either not responded, or not returned the requested information, then the Pharmacy PCN Lead will assume the contractor does not want to be involved in these domains. The activity therefore would proceed without the contractors that have not responded.

Q. On the day of declaration are all pharmacy staff required to have completed the appropriate e-learning for a domain, or is this deadline now extended to 30th June 2021?

Contractors wanting to declare against a domain that has any training requirements will still need to make their PQS Part 2 2020/21 declaration as planned in February 2021. However, contractors will have until 30th June 2021 to ensure their teams have collated the evidence to demonstrate that they are compliant with the required levels of training associated with the domains they declare for.

Q. How will this extension work for new starters?

Guidance regarding new starters, or those recently returning to work in the pharmacy is already specified in the PQS guidance. While the guidance is for an action plan to be in place and training to have been completed within 30 days of declaration, the same flexibility for training (i.e. extension to 30th June 2021 to collate the evidence) will apply to the requirements. New starters joining after the point of declaration would not be included in the staffing contingent at the declaration and for whom evidence may be required for any Post Payment Verification (PPV).

Q. Is it possible to complete the PQS declaration as a bulk submission for multiple pharmacies?

No. PQS declarations must be submitted as an individual pharmacy submission. There is no facility to submit a bulk declaration on behalf of multiple pharmacies.

Primary Care Network (PCN) Domains

Q. Our Pharmacy PCN Lead has resigned or left the role; are we still allowed to make declarations against the PQS PCN domains?

Where a Pharmacy PCN Lead resigns or leaves the role, but the required activities had been completed before they resigned or left the role, the contractor will still be able to make their declaration as the PCN Lead.

Contractors aligned to the PCN are also able to declare against the PCN domains where they were involved and contributed to the PCN domains and have met the requirements of the domains.

Q. Where a Pharmacy PCN Lead has not managed to get meetings in place with contractors before the end of the declaration period, how will this impact contractors aligned to that PCN?

If the activities required by the domain do not occur, then contractors aligned with that PCN cannot declare against that domain. The contractors who elected their Pharmacy PCN Lead need to hold them to account to undertake the activity and support meeting the requirements of the domain(s).

If there are problems with the ways of working in the PCN or a lack of activity by a Lead, the assistance of the LPC could be sought. The two PCN domains require collaboration with the Pharmacy PCN Lead, between contractors aligned with the PCN and with the PCN. This collaboration therefore requires active management within the group of contractors. This potentially has implications moving forwards as NHSE&I have been clear in their commitment to developing integrated community-based health care via PCNs.

Q. Can Pharmacy PCN leads still be recruited to assist with completion of PQS PCN activity by 30th June 2021?

Pharmacy PCN Leads can continue to be recruited where gaps occur, however domain 4 activity can only occur until 31st of January 2021. Domain 5 activity would need to have been substantively undertaken, including the contractor meeting, to meet the requirements of the domain before the end of the declaration period. The collation of information and preparation of the required report can occur up to 30th June 2021.

Q. If a PCN Clinical Director or their agreed lead does not engage with the Pharmacy PCN Lead, does this mean that contractors aligned to the PCN cannot declare against that domain?

No. If a lead other than the PCN Clinical Director has been assigned to work with community pharmacy and that individual is not engaging with the Pharmacy PCN Lead, then in the first instance, and with LPC support, the Clinical Director’s support should be sought.

If the PCN Clinical Director is not engaging with the Pharmacy PCN Lead and the Lead has made best endeavours to make contact and progress the requirements of the PQS domains with the Clinical Director, as long as all other aspects of the domain have been undertaken, a claim for the domain could be made by the lead and any participating contractors. The Lead would need to retain evidence to demonstrate the attempts they made to make contact and engage with the Clinical Director (e.g. email trails).

The key points for the 2 PCN domains are:

Domain 4 – Primary Care Network (PCN) – Prevention

  • This work must be completed by the 31st January 2021 as this was the deadline given for recording the data required for this Domain. There is no extension here and so activities of gaining information back from pharmacies and providing the collated report to the PCN Clinical Director must be complete by the 31st January 2021 for you and all pharmacies in the PCN to declare compliance in the declaration window (4TH February 2021 – 1st March 2021)

If you have NOT been able to complete all the actions to declare Domains 4, please contact rikki.smeeton@gmlpc.org.uk for advice.

Domain 5 – Primary Care Network – Business continuity 

  • The contractor discussion must take place before the declaration is made by any contractor in the PCN (the declaration window is open from 4th February 2021 – 1st March 2021). An email chain or WhatsApp exchange does not constitute a discussion for the purposes of this domain, nor does it allow for the intention, which is to share, learn and therefore develop a collated document that further supports business continuity plans more fully, to be achieved.
  • PSNC have agreed that collating evidence and BCP information can be pushed back if necessary until 30th June 2021, so if you as a PCN Lead don’t have all the relevant information from your contractors already, you must get written assurance that they intend to complete the work necessary before the 30th June 2021 deadline (i.e provide you with the information outlined in the contractor survey). However, to avoid the need for additional assurance from pharmacies we strongly recommend that you gather all of the information required from contractors in the PCN before you make your declaration during the February declaration window
  • For those pharmacies who do not initially engage ensure you have attempted to contact them at least three times in at least two different ways and retain evidence of this
  • When finalised, the collated BCP report must be submitted to the pharmacies in your PCN, the Clinical Director, the LPC and the NHSE Local Team

If you believe that you will not be able to complete all actions required for Domain 5 before the end of the declaration window (1st March 2021) please contact the LPC urgently for advice

For those have you that have completed all actions and are ready to declare, please ensure you update rikki.smeeton@gmlpc.org.uk . (This includes having had a meeting with your Clinical Director (or making best endeavours for this to have taken place) – See FAQ for further details.

If you are part of a multiple pharmacy group and not making your own declaration, please ensure the person completing the submission has all the relevant information.

 

Completing Your Declaration

Community pharmacy contractors will be able to make a declaration for a Pharmacy Quality Scheme (PQS) payment for the 2020/21 Part 2 Scheme between 09:00 on Thursday 4th February 2021 and 23:59 on Monday 1st March 2021.

This PSNC Briefing provides further information on how to make a declaration for the Scheme and the validation process for the Gateway criteria. View the PSNC Briefing here

If you have any queries on this PSNC Briefing or you require more information, please contact the PSNC Services Team.